Cargando…

The importance of endothelial protection: the emerging role of defibrotide in reversing endothelial injury and its sequelae

Hepatic veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS), a potentially life-threatening complication of hematopoietic cell transplantation (HCT), results from prolonged sinusoidal endothelial cell activation and profound endothelial cell damage, with sequelae. Defibrotide, the only...

Descripción completa

Detalles Bibliográficos
Autores principales:	Richardson, Paul G., Palomo, Marta, Kernan, Nancy A., Hildebrandt, Gerhard C., Chao, Nelson, Carreras, Enric
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8477726/ https://www.ncbi.nlm.nih.gov/pubmed/34584241 http://dx.doi.org/10.1038/s41409-021-01383-x

Ejemplares similares

Up‐regulation of HDACs, a harbinger of uraemic endothelial dysfunction, is prevented by defibrotide
por: Palomo, Marta, et al.
Publicado: (2019)

Defibrotide inhibits donor leucocyte‐endothelial interactions and protects against acute graft‐versus‐host disease
por: García‐Bernal, David, et al.
Publicado: (2020)

Acute Graft-vs.-Host Disease-Associated Endothelial Activation in vitro Is Prevented by Defibrotide
por: Martinez-Sanchez, Julia, et al.
Publicado: (2019)

Defibrotide for the Treatment of Endotheliitis Complicating Sars-Cov-2 Infection: Rationale and Ongoing Studies As Part of the International Defacovid Study Group
por: Moraleda, Jose M., et al.
Publicado: (2020)

Endothelial Dysfunction in Hematopoietic Cell Transplantation
por: Palomo, Marta, et al.
Publicado: (2019)

Endothelial dysfunction and its critical role in COVID‐19‐associated coagulopathy: Defibrotide as an endothelium‐protective, targeted therapy
por: García‐Bernal, David, et al.
Publicado: (2021)

Endothelial cell function and endothelial‐related disorders following haematopoietic cell transplantation
por: Hildebrandt, Gerhard C., et al.
Publicado: (2020)

Pre-Exposure to Defibrotide Prevents Endothelial Cell Activation by Lipopolysaccharide: An Ingenuity Pathway Analysis
por: Orlando, Nicoletta, et al.
Publicado: (2020)

Incidence of Anicteric Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome and Outcomes with Defibrotide following Hematopoietic Cell Transplantation in Adult and Pediatric Patients
por: Corbacioglu, Selim, et al.
Publicado: (2020)

Defibrotide mitigates endothelial cell injury induced by plasmas from patients with COVID-19 and related vasculopathies
por: Elhadad, Sonia, et al.
Publicado: (2023)

Endothelium-protective, histone-neutralizing properties of the polyanionic agent defibrotide
por: Shi, Hui, et al.
Publicado: (2021)

Analysis of Time to Complete Response after Defibrotide Initiation in Patients with Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Hematopoietic Cell Transplantation
por: Richardson, Paul G., et al.
Publicado: (2020)

Defibrotide modulates pulmonary endothelial cell activation and protects against lung inflammation in pre-clinical models of LPS-induced lung injury and idiopathic pneumonia syndrome
por: Klein, Orly R., et al.
Publicado: (2023)

Final results from a defibrotide treatment‐IND study for patients with hepatic veno‐occlusive disease/sinusoidal obstruction syndrome
por: Kernan, Nancy A., et al.
Publicado: (2018)

Defibrotide for hepatic veno-occlusive disease
Publicado: (2021)

Defibrotide Therapy for SARS-CoV-2 ARDS
por: Frame, David, et al.
Publicado: (2022)

Pooled analysis of Day 100 survival for defibrotide‐treated patients with hepatic veno‐occlusive disease/sinusoidal obstruction syndrome and ventilator or dialysis dependence following haematopoietic cell transplantation
por: Richardson, Paul G., et al.
Publicado: (2020)

Pharmacokinetic profile of defibrotide in patients with renal impairment
por: Tocchetti, Paola, et al.
Publicado: (2016)

Defibrotide in the treatment of hepatic veno-occlusive disease
por: Fulgenzi, Alessandro, et al.
Publicado: (2016)

Pharmacokinetics and Safety of Defibrotide in Healthy Japanese Subjects
por: Umemura, Kazuo, et al.
Publicado: (2016)

Defibrotide Has a Role in COVID-19 Therapy
por: Macciò, Antonio, et al.
Publicado: (2022)

Defibrotide Therapy for Sars CoV2 Acute Respiratory Distress Syndrome
por: Yanik, Gregory A, et al.
Publicado: (2021)

Use of Defibrotide to help prevent post-transplant endothelial injury in a genetically predisposed infant with metachromatic leukodystrophy undergoing hematopoietic stem cell gene therapy
por: Calbi, Valeria, et al.
Publicado: (2018)

Response to Maccio et al, “Multifactorial pathogenesis of COVID‐19‐related coagulopathy: Can defibrotide have a role in the early phases of coagulation disorders?”
por: Richardson, Edward, et al.
Publicado: (2020)

Endothelial damage and dysfunction in acute graft-versus-host disease
por: Cordes, Steffen, et al.
Publicado: (2020)

Systematic review of defibrotide studies in the treatment of veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS)
por: Richardson, Paul, et al.
Publicado: (2019)

Early vascular endothelial complications after hematopoietic cell transplantation: Role of the endotheliopathy in biomarkers and target therapies development
por: Moreno-Castaño, Ana Belén, et al.
Publicado: (2022)

Differential protein expression in endothelial cells exposed to serum from patients with acute graft‐vs‐host disease, depending on steroid response
por: Martinez‐Sanchez, Julia, et al.
Publicado: (2023)

Differences and similarities in endothelial and angiogenic profiles of preeclampsia and COVID-19 in pregnancy
por: Palomo, Marta, et al.
Publicado: (2022)

Veno-occlusive disease/sinusoidal obstruction syndrome in patients with prior gemtuzumab ozogamicin: literature analysis of survival after defibrotide treatment
por: Richardson, Paul G., et al.
Publicado: (2020)

Publisher Correction: Systematic review of defibrotide studies in the treatment of veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS)
por: Richardson, Paul, et al.
Publicado: (2019)

Influence of creatinine levels on survival in patients with veno-occlusive disease treated with defibrotide
por: Kong, Seom Gim, et al.
Publicado: (2022)

Defibrotide improved the outcome of monocrotaline induced rat hepatic sinusoidal obstruction syndrome
por: Liu, Zhenli, et al.
Publicado: (2022)

Defibrotide: real-world management of veno-occlusive disease/sinusoidal obstructive syndrome after stem cell transplant
por: Nauffal, Mary, et al.
Publicado: (2022)

Complement Mediated Endothelial Damage in Thrombotic Microangiopathies
por: Blasco, Miquel, et al.
Publicado: (2022)

Use of Defibrotide in Patients with COVID-19 Pneumonia; Results of the Defi-VID19 Phase 2 Trial
por: Ruggeri, Annalisa, et al.
Publicado: (2021)

Reversal of emphysema by restoration of pulmonary endothelial cells
por: Hisata, Shu, et al.
Publicado: (2021)

Defibrotide (Defitelio): A New Addition to the Stockpile of Food and Drug Administration-approved Oligonucleotide Drugs
por: Stein, Cy, et al.
Publicado: (2016)

Defibrotide impact on the acute GVHD disease incidence in pediatric hematopoietic stem cell transplant recipients
por: Squillaci, Domenica, et al.
Publicado: (2023)

Endothelial hyperplasia: an important indicator of actual angiogenesis
por: Beranek, J T
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_mnn4s2o9h2lqjpnrbekocrn6n4